{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:11:49Z","timestamp":1790878309918,"version":"4.1.0"},"reference-count":167,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH\/NINDS","award":["NS053912"],"award-info":[{"award-number":["NS053912"]}]},{"name":"NIH\/NINDS","award":["NS061257"],"award-info":[{"award-number":["NS061257"]}]},{"name":"NSF","award":["REU #DBI1062963"],"award-info":[{"award-number":["REU #DBI1062963"]}]},{"name":"High Q Foundation"},{"name":"Hereditary Disease Foundation\/Cure HD Initiative"},{"DOI":"10.13039\/100000887","name":"Huntington's Disease Society of America","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000887","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neurobiology"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.pneurobio.2011.11.004","type":"journal-article","created":{"date-parts":[[2011,11,19]],"date-time":"2011-11-19T02:01:36Z","timestamp":1321668096000},"page":"190-204","source":"Crossref","is-referenced-by-count":55,"title":["Engineered antibody therapies to counteract mutant huntingtin and related toxic intracellular proteins"],"prefix":"10.1016","volume":"97","author":[{"given":"David C.","family":"Butler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"McLear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Messer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pneurobio.2011.11.004_bib0010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/scdb.1999.0347","article-title":"Roles of molecular chaperones in cytoplasmic protein folding","volume":"11","author":"Agashe","year":"2000","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0015","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1073\/pnas.0500055102","article-title":"Identification of combinatorial drug regimens for treatment of Huntington's disease using Drosophila","volume":"102","author":"Agrawal","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0020","doi-asserted-by":"crossref","first-page":"29427","DOI":"10.1074\/jbc.M109.013193","article-title":"Phosphorylation of threonine 3: implications for Huntingtin aggregation and neurotoxicity","volume":"284","author":"Aiken","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0025","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jmb.2004.04.062","article-title":"Camelized rabbit-derived VH single-domain intrabodies against Vif strongly neutralize HIV-1 infectivity","volume":"340","author":"Aires da Silva","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0030","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1089\/hum.2010.202","article-title":"Good manufacturing practice production of self-complementary serotype 8 adeno-associated viral vector for a hemophilia B clinical trial","volume":"22","author":"Allay","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0830","doi-asserted-by":"crossref","first-page":"84ra43","DOI":"10.1126\/scitranslmed.3002254","article-title":"A therapeutic antibody targeting BACE1 inhibits amyloid-beta production in vivo","volume":"3","author":"Atwal","year":"2011","journal-title":"Sci Transl Med."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0040","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1093\/hmg\/ddm217","article-title":"Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity","volume":"16","author":"Atwal","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0045","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1093\/hmg\/10.22.2515","article-title":"The HD mutation causes progressive lethal neurological disease in mice expressing reduced levels of huntingtin","volume":"10","author":"Auerbach","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0050","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0014-5793(01)03101-5","article-title":"Antigen-independent selection of stable intracellular single-chain antibodies","volume":"508","author":"Auf der Maur","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0055","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/protein\/gzl036","article-title":"Isolating recombinant antibodies against specific protein morphologies using atomic force microscopy and phage display technologies","volume":"19","author":"Barkhordarian","year":"2006","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0060","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1534\/genetics.106.056945","article-title":"Site-specific transformation of Drosophila via phiC31 integrase-mediated cassette exchange","volume":"173","author":"Bateman","year":"2006","journal-title":"Genetics"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0065","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nbt.1608","article-title":"Harnessing chaperone-mediated autophagy for the selective degradation of mutant huntingtin protein","volume":"28","author":"Bauer","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0070","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1006\/nbdi.1998.0168","article-title":"Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length","volume":"4","author":"Becher","year":"1998","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0075","first-page":"852","article-title":"Intranuclear neuronal inclusions in DRPLA","volume":"13","author":"Becher","year":"1998","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0080","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1513\/pats.200909-102JS","article-title":"Chaperone-mediated autophagy","volume":"7","author":"Bejarano","year":"2010","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0085","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1073\/pnas.0611511104","article-title":"An optimized transgenesis system for Drosophila using germ-line-specific phiC31 integrases","volume":"104","author":"Bischof","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0090","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0076-6879(00)28410-3","article-title":"Yeast surface display for directed evolution of protein expression, affinity, and stability","volume":"328","author":"Boder","year":"2000","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0095","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.nbd.2010.04.007","article-title":"Cystamine and intrabody co-treatment confers additional benefits in a fly model of Huntington's disease","volume":"40","author":"Bortvedt","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0100","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1093\/hmg\/ddr137","article-title":"RNAi medicine for the brain: progresses and challenges","volume":"20","author":"Boudreau","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0105","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1093\/hmg\/ddr110","article-title":"Genetic therapy for the nervous system","volume":"20","author":"Bowers","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0110","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1242\/dev.118.2.401","article-title":"Targeted gene expression as a means of altering cell fates and generating dominant phenotypes","volume":"118","author":"Brand","year":"1993","journal-title":"Development"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0835","doi-asserted-by":"crossref","unstructured":"Butler, D. C. and Messer, A. 2011. Bifunctional anti-Huntingtin Proteasome-Directed Intrabodies Mediate Efficient Degradation of Mutant Huntingtin Exon 1 Protein Fragments. PLoS ONE, in Press.","DOI":"10.1371\/journal.pone.0029199"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0115","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.molmed.2008.07.004","article-title":"The potential of intracellular antibodies for therapeutic targeting of protein-misfolding diseases","volume":"14","author":"Cardinale","year":"2008","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0120","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1128\/MCB.8.6.2638","article-title":"A new means of inducibly inactivating a cellular protein","volume":"8","author":"Carlson","year":"1988","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0125","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.tcb.2009.01.005","article-title":"Huntingtin as an essential integrator of intracellular vesicular trafficking","volume":"19","author":"Caviston","year":"2009","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0130","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/mt.2008.166","article-title":"Expanded repertoire of AAV vector serotypes mediate unique patterns of transduction in mouse brain","volume":"16","author":"Cearley","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0135","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pneurobio.2006.11.001","article-title":"The corticostriatal pathway in Huntington's disease","volume":"81","author":"Cepeda","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0140","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1093\/hmg\/ddp101","article-title":"Prevention of oculopharyngeal muscular dystrophy by muscular expression of Llama single-chain intrabodies in vivo","volume":"18","author":"Chartier","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0145","doi-asserted-by":"crossref","first-page":"17616","DOI":"10.1073\/pnas.0408134101","article-title":"Potent inhibition of huntingtin aggregation and cytotoxicity by a disulfide bond-free single-domain intracellular antibody","volume":"101","author":"Colby","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0150","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jmb.2004.07.054","article-title":"Development of a human light chain variable domain (V(L)) intracellular antibody specific for the amino terminus of huntingtin via yeast surface display","volume":"342","author":"Colby","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0155","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0076-6879(04)88027-3","article-title":"Engineering antibody affinity by yeast surface display","volume":"388","author":"Colby","year":"2004","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0160","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ng1503","article-title":"Polyglutamine expansion of huntingtin impairs its nuclear export","volume":"37","author":"Cornett","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0165","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neuron.2010.12.035","article-title":"Huntington's disease: can mice lead the way to treatment?","volume":"69","author":"Crook","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0170","doi-asserted-by":"crossref","first-page":"11550","DOI":"10.1523\/JNEUROSCI.3307-09.2009","article-title":"Striatal expression of a calmodulin fragment improved motor function, weight loss, and neuropathology in the R6\/2 mouse model of Huntington's disease","volume":"29","author":"Dai","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0175","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cell.2005.09.017","article-title":"The blood\u2013brain barrier\u2014lessons from moody flies","volume":"123","author":"Daneman","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0180","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0014-5793(94)80432-X","article-title":"\u2019Camelising\u2019 human antibody fragments: NMR studies on VH domains","volume":"339","author":"Davies","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0185","doi-asserted-by":"crossref","first-page":"8942","DOI":"10.1523\/JNEUROSCI.22-20-08942.2002","article-title":"Therapeutic effects of cystamine in a murine model of Huntington's disease","volume":"22","author":"Dedeoglu","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0190","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0195","doi-asserted-by":"crossref","first-page":"17204","DOI":"10.1073\/pnas.0708285104","article-title":"Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits","volume":"104","author":"DiFiglia","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0200","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1517\/14712598.7.5.677","article-title":"Intrabody strategies for the treatment of human papillomavirus-associated disease","volume":"7","author":"Doorbar","year":"2007","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/gene.10150","article-title":"GAL4 system in Drosophila: a fly geneticist's Swiss army knife","volume":"34","author":"Duffy","year":"2002","journal-title":"Genesis"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0210","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.7618107","article-title":"Inactivation of the mouse Huntington's disease gene homolog Hdh","volume":"269","author":"Duyao","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0215","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jmb.2007.02.089","article-title":"Isolation of a human single chain antibody fragment against oligomeric alpha-synuclein that inhibits aggregation and prevents alpha-synuclein-induced toxicity","volume":"368","author":"Emadi","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0220","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1021\/bi036281f","article-title":"Inhibiting aggregation of a-synuclein with human single chain antibody fragments","volume":"43","author":"Emadi","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0225","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2174\/0929867043456160","article-title":"Cationic lipid\u2013DNA complexes for gene therapy: understanding the relationship between complex structure and gene delivery pathways at the molecular level","volume":"11","author":"Ewert","year":"2004","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0230","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nbt785","article-title":"Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library","volume":"21","author":"Feldhaus","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0235","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0240","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1126\/science.2928784","article-title":"Prevention of rapid intracellular degradation of ODC by a carboxyl-terminal truncation","volume":"243","author":"Ghoda","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0245","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice","volume":"28","author":"Gray","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0250","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/mt.2011.72","article-title":"Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates","volume":"19","author":"Gray","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0255","first-page":"397","article-title":"Conditional inactivation of HIF-1 using intrabodies","volume":"30","author":"Groot","year":"2008","journal-title":"Cell Oncol."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0260","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.neuron.2009.11.020","article-title":"Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice","volume":"64","author":"Gu","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0265","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1523\/JNEUROSCI.19-07-02522.1999","article-title":"Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology","volume":"19","author":"Gutekunst","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0270","doi-asserted-by":"crossref","first-page":"19232","DOI":"10.1073\/pnas.0703793104","article-title":"Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Abeta protofibrils","volume":"104","author":"Habicht","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0275","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00253-007-1142-2","article-title":"Properties, production, and applications of camelid single-domain antibody fragments","volume":"77","author":"Harmsen","year":"2007","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0280","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.nbd.2010.08.017","article-title":"Nicotinamide improves motor deficits and upregulates PGC-1alpha and BDNF gene expression in a mouse model of Huntington's disease","volume":"41","author":"Hathorn","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0285","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2174\/187152710791556104","article-title":"Drosophila melanogaster in the study of human neurodegeneration","volume":"9","author":"Hirth","year":"2010","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0290","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1073\/pnas.0437870100","article-title":"Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease","volume":"100","author":"Hockly","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0295","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/hmg\/7.5.913","article-title":"Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions","volume":"7","author":"Holmberg","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0300","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.tibtech.2003.08.007","article-title":"Domain antibodies: proteins for therapy","volume":"21","author":"Holt","year":"2003","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0305","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1432-1033.1993.tb18026.x","article-title":"Isolation, characterization and expression of the eclosion hormone gene of Drosophila melanogaster","volume":"215","author":"Horodyski","year":"1993","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0310","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1042\/BJ20071619","article-title":"Huntington's disease: from pathology and genetics to potential therapies","volume":"412","author":"Imarisio","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0315","doi-asserted-by":"crossref","first-page":"11635","DOI":"10.1074\/jbc.M412042200","article-title":"Co-chaperone CHIP associates with expanded polyglutamine protein and promotes their degradation by proteasomes","volume":"280","author":"Jana","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0320","doi-asserted-by":"crossref","first-page":"14580","DOI":"10.1073\/pnas.93.25.14580","article-title":"Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: relevance to diseases of the nervous system","volume":"93","author":"Kahlem","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0325","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0330","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1073\/pnas.022631799","article-title":"Effects of intracellular expression of anti-huntingtin antibodies of various specificities on mutant huntingtin aggregation and toxicity","volume":"99","author":"Khoshnan","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0335","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/sj.mt.6300331","article-title":"AAV8, 9, Rh10, Rh43 vector gene transfer in the rat brain: effects of serotype, promoter and purification method","volume":"16","author":"Klein","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0340","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0361-9230(01)00599-8","article-title":"New anti-huntingtin monoclonal antibodies: implications for huntingtin conformation and its binding proteins","volume":"56","author":"Ko","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0345","doi-asserted-by":"crossref","first-page":"e5727","DOI":"10.1371\/journal.pone.0005727","article-title":"Conformational targeting of fibrillar polyglutamine proteins in live cells escalates aggregation and cytotoxicity","volume":"4","author":"Kvam","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0350","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/protein\/gzq022","article-title":"Physico-chemical determinants of soluble intrabody expression in mammalian cell cytoplasm","volume":"23","author":"Kvam","year":"2010","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0355","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nrg2748","article-title":"Repeat expansion disease: progress and puzzles in disease pathogenesis","volume":"11","author":"La Spada","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0360","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.1073\/pnas.071058398","article-title":"Human single-chain Fv intrabodies counteract in situ huntingtin aggregation in cellular models of Huntington's disease","volume":"98","author":"Lecerf","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0365","doi-asserted-by":"crossref","first-page":"590","DOI":"10.2144\/00293rr02","article-title":"Development of a destabilized firefly luciferase enzyme for measurement of gene expression","volume":"29","author":"Leclerc","year":"2000","journal-title":"Biotechniques"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0370","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0166-2236(00)01791-4","article-title":"Mosaic analysis with a repressible cell marker (MARCM) for Drosophila neural development","volume":"24","author":"Lee","year":"2001","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0375","article-title":"Viral vectors for gene delivery to the central nervous system","author":"Lentz","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0380","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/276565a0","article-title":"A gene complex controlling segmentation in Drosophila","volume":"276","author":"Lewis","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0385","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nsmb1234","article-title":"The structure of a polyQ\u2013anti-polyQ complex reveals binding according to a linear lattice model","volume":"14","author":"Li","year":"2007","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0390","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/mt.2008.100","article-title":"Engineering and selection of shuffled AAV genomes: a new strategy for producing targeted biological nanoparticles","volume":"16","author":"Li","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0395","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1093\/hmg\/ddq127","article-title":"Inhibiting the ubiquitin-proteasome system leads to preferential accumulation of toxic N-terminal mutant huntingtin fragments","volume":"19","author":"Li","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0400","doi-asserted-by":"crossref","first-page":"34970","DOI":"10.1074\/jbc.273.52.34970","article-title":"Generation of destabilized green fluorescent protein as a transcription reporter","volume":"273","author":"Li","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0405","first-page":"6","article-title":"Clearance of mutant huntingtin","author":"Li","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0410","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.nbd.2010.11.018","article-title":"Proteasomal dysfunction in aging and Huntington disease","volume":"43","author":"Li","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0415","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/978-3-540-73259-4_15","article-title":"Intracellular antibodies (intrabodies) and their therapeutic potential","author":"Lo","year":"2008","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0420","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S1471-4914(03)00163-1","article-title":"Intracellular antibodies and challenges facing their use as therapeutic agents","volume":"9","author":"Lobato","year":"2003","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0425","doi-asserted-by":"crossref","first-page":"7215","DOI":"10.4049\/jimmunol.0903833","article-title":"Systemic inflammation modulates Fc receptor expression on microglia during chronic neurodegeneration","volume":"186","author":"Lunnon","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0430","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jmb.2007.11.096","article-title":"An scFv intrabody against the nonamyloid component of alpha-synuclein reduces intracellular aggregation and toxicity","volume":"377","author":"Lynch","year":"2008","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0435","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0440","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1089\/hum.1998.9.11-1627","article-title":"Intracellular antibodies against HIV-1 envelope protein for AIDS gene therapy","volume":"9","author":"Marasco","year":"1998","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0445","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1006\/jmbi.1998.1840","article-title":"Expression of an antibody fragment at high levels in the bacterial cytoplasm","volume":"280","author":"Martineau","year":"1998","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0450","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/sj.gt.3301514","article-title":"Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis","volume":"8","author":"McCarty","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0455","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1096\/fj.07-099689","article-title":"Combinational approach of intrabody with enhanced Hsp70 expression addresses multiple pathologies in a fly model of Huntington's disease","volume":"22","author":"McLear","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0460","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jmb.2007.09.053","article-title":"A protein silencing switch by ligand-induced proteasome-targeting intrabodies","volume":"374","author":"Melchionna","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0465","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1517\/14712590903176387","article-title":"Developing intrabodies for the therapeutic suppression of neurodegenerative pathology","volume":"9","author":"Messer","year":"2009","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0470","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00063030-200620060-00002","article-title":"The therapeutic potential of intrabodies in neurologic disorders: focus on huntington and Parkinson diseases","volume":"20","author":"Messer","year":"2006","journal-title":"BioDrugs"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0840","series-title":"Gene Therapy of the Central Nervous System: From Bench to Bedside","first-page":"133","article-title":"Gene therapy for CNS diseases using intrabodies","author":"Miller","year":"2006"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0475","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S1525-0016(03)00063-7","article-title":"DNA vaccination against mutant huntingtin ameliorates the HDR6\/2 diabetic phenotype","volume":"7","author":"Miller","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0480","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.nbd.2004.11.003","article-title":"A human single-chain Fv intrabody preferentially targets amino-terminal Huntingtin's fragments in striatal models of Huntington's disease","volume":"19","author":"Miller","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0485","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature06639","article-title":"Autophagy fights disease through cellular self-digestion","volume":"451","author":"Mizushima","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0490","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.biocel.2008.07.001","article-title":"Single-chain intracellular antibodies inhibit influenza virus replication by disrupting interaction of proteins involved in viral replication and transcription","volume":"41","author":"Mukhtar","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0495","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.molbrainres.2003.11.011","article-title":"A single-chain Fv intrabody provides functional protection against the effects of mutant protein in an organotypic slice culture model of Huntington's disease","volume":"121","author":"Murphy","year":"2004","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0500","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.vetimm.2008.10.299","article-title":"Camelid immunoglobulins and nanobody technology","volume":"128","author":"Muyldermans","year":"2009","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0505","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/hmg\/ddg144","article-title":"Prevention of polyglutamine oligomerization and neurodegeneration by the peptide inhibitor QBP1 in Drosophila","volume":"12","author":"Nagai","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0510","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nsmb1215","article-title":"A toxic monomeric conformer of the polyglutamine protein","volume":"14","author":"Nagai","year":"2007","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0515","doi-asserted-by":"crossref","first-page":"10437","DOI":"10.1074\/jbc.275.14.10437","article-title":"Inhibition of polyglutamine protein aggregation and cell death by novel peptides identified by phage display screening","volume":"275","author":"Nagai","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0520","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/287795a0","article-title":"Mutations affecting segment number and polarity in Drosophila","volume":"287","author":"Nusslein-Volhard","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0525","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1073\/pnas.022662599","article-title":"Conformational Abs recognizing a generic amyloid fibril epitope","volume":"99","author":"O\u2019Nuallain","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0530","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.neulet.2007.11.018","article-title":"14-3-3zeta is indispensable for aggregate formation of polyglutamine-expanded huntingtin protein","volume":"431","author":"Omi","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0535","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1073\/pnas.86.10.3833","article-title":"Cloning immunoglobulin variable domains for expression by the polymerase chain reaction","volume":"86","author":"Orlandi","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0540","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/ana.410410408","article-title":"Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain","volume":"41","author":"Paulson","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0545","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1158\/1535-7163.MCT-05-0174","article-title":"Human single-domain neutralizing intrabodies directed against Etk kinase: a novel approach to impair cellular transformation","volume":"4","author":"Paz","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0550","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1002\/prot.23085","article-title":"Mutational analysis of domain antibodies reveals aggregation hotspots within and near the complementarity determining regions","volume":"79","author":"Perchiacca","year":"2011","journal-title":"Proteins"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0555","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/bies.201000009","article-title":"Intracellular antibodies and cancer: new technologies offer therapeutic opportunities","volume":"32","author":"Perez-Martinez","year":"2010","journal-title":"Bioessays"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(96)00627-0","article-title":"Targeting vectors for intracellular immunisation","volume":"187","author":"Persic","year":"1997","journal-title":"Gene"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0565","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/sj.mt.6300045","article-title":"Protein transduction domain-mediated delivery of QBP1 suppresses polyglutamine-induced neurodegeneration in vivo","volume":"15","author":"Popiel","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0570","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neulet.2008.06.015","article-title":"Delivery of the aggregate inhibitor peptide QBP1 into the mouse brain using PTDs and its therapeutic effect on polyglutamine disease mice","volume":"449","author":"Popiel","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0575","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1523\/JNEUROSCI.1409-03.2004","article-title":"Huntingtin bodies sequester vesicle-associated proteins by a polyproline-dependent interaction","volume":"24","author":"Qin","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0580","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/hmg\/11.9.1107","article-title":"Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy","volume":"11","author":"Ravikumar","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0585","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1006\/bbrc.2001.5783","article-title":"Amino acid sequence requirements of peptides that inhibit polyglutamine\u2013protein aggregation and cell death","volume":"288","author":"Ren","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0590","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/hmg\/ddl440","article-title":"The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis","volume":"16","author":"Rockabrand","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0595","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ymthe.2005.05.006","article-title":"Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6\/1 Huntington's disease transgenic mice","volume":"12","author":"Rodriguez-Lebron","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0600","first-page":"327","article-title":"Nanobodies in therapeutic applications","volume":"9","author":"Roovers","year":"2007","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0605","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1093\/hmg\/ddq093","article-title":"Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease","volume":"19","author":"Rose","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0610","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jmb.2005.07.038","article-title":"Identification of a universal VHH framework to graft non-canonical antigen-binding loops of camel single-domain antibodies","volume":"352","author":"Saerens","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0615","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1172\/JCI45130","article-title":"Oligonucleotide therapeutic approaches for Huntington disease","volume":"121","author":"Sah","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0620","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/ana.410420411","article-title":"Huntingtin localization in brains of normal and Huntington's disease patients","volume":"42","author":"Sapp","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0625","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1111\/j.1742-4658.2008.06562.x","article-title":"Huntington's disease: degradation of mutant huntingtin by autophagy","volume":"275","author":"Sarkar","year":"2008","journal-title":"FEBS J."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2011.09.034","article-title":"A disulfide-free single-domain V(L) intrabody with blocking activity towards huntingtin reveals a novel mode of epitope recognition","author":"Schiefner","year":"2011","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0635","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","article-title":"Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin","volume":"8","author":"Schilling","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0640","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1152\/jn.00718.2010","article-title":"Synaptic transmission and plasticity are modulated by nonmuscle myosin II at the neuromuscular junction of Drosophila","volume":"105","author":"Seabrooke","year":"2011","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0645","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.nano.2007.06.001","article-title":"Single-molecule selection and recovery of structure-specific antibodies using atomic force microscopy","volume":"3","author":"Shlyakhtenko","year":"2007","journal-title":"Nanomedicine"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0650","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.molimm.2005.10.012","article-title":"A novel designed single domain antibody on 3-D structure of ricin A chain remarkably blocked ricin-induced cytotoxicity","volume":"43","author":"Shuntao","year":"2006","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0655","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1111\/j.1742-4658.2005.04709.x","article-title":"Extended half-life upon binding of destabilized intrabodies allows specific detection of antigen in mammalian cells","volume":"272","author":"Sibler","year":"2005","journal-title":"FEBS J."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0660","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.0305-1846.2001.00299.x","article-title":"The selective vulnerability of nerve cells in Huntington's disease","volume":"27","author":"Sieradzan","year":"2001","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0665","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/40153","article-title":"Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures","volume":"389","author":"Skinner","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0670","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0675","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1097\/NEN.0b013e3181f530ec","article-title":"Early or late-stage anti-N-terminal Huntingtin intrabody gene therapy reduces pathological features in B6.HDR6\/1 mice","volume":"69","author":"Snyder-Keller","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0680","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.neuropharm.2010.04.004","article-title":"Immunotherapy for Alzheimer's disease","volume":"59","author":"Solomon","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0685","doi-asserted-by":"crossref","first-page":"e16676","DOI":"10.1371\/journal.pone.0016676","article-title":"Perturbation with intrabodies reveals that calpain cleavage is required for degradation of huntingtin exon 1","volume":"6","author":"Southwell","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0690","doi-asserted-by":"crossref","first-page":"9013","DOI":"10.1523\/JNEUROSCI.2747-08.2008","article-title":"Intrabodies binding the proline-rich domains of mutant huntingtin increase its turnover and reduce neurotoxicity","volume":"28","author":"Southwell","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0695","doi-asserted-by":"crossref","first-page":"13589","DOI":"10.1523\/JNEUROSCI.4286-09.2009","article-title":"Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington's disease","volume":"29","author":"Southwell","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0700","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/1073858410386236","article-title":"Gene therapy in mouse models of huntington disease","volume":"17","author":"Southwell","year":"2011","journal-title":"Neuroscientist"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0705","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1126\/science.1092194","article-title":"SUMO modification of Huntingtin and Huntington's disease pathology","volume":"304","author":"Steffan","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0845","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","article-title":"Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila","volume":"413","author":"Steffan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0715","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1073\/pnas.97.2.805","article-title":"Functional deletion of the CCR5 receptor by intracellular immunization produces cells that are refractory to CCR5-dependent HIV-1 infection and cell fusion","volume":"97","author":"Steinberger","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0720","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1126\/science.37.965.990","article-title":"A third group of linked genes in drosophila ampelophila","volume":"37","author":"Sturtevant","year":"1913","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0725","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1038\/mt.2009.174","article-title":"Generating differentially targeted amyloid-beta specific intrabodies as a passive vaccination strategy for Alzheimer's disease","volume":"17","author":"Sudol","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0730","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1074\/jbc.M110.188193","article-title":"Single domain intracellular antibodies from diverse libraries: emphasizing dual functions of LMO2 protein interactions using a single VH domain","volume":"286","author":"Tanaka","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0735","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1038\/sj.emboj.7601744","article-title":"Tumour prevention by a single antibody domain targeting the interaction of signal transduction proteins with RAS","volume":"26","author":"Tanaka","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0005","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0740","series-title":"High-Throughput and High-Content Screening for Huntington's Disease Therapeutics","author":"Varma","year":"2011"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0745","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1126\/science.1134426","article-title":"P[acman]: a BAC transgenic platform for targeted insertion of large DNA fragments in D. melanogaster","volume":"314","author":"Venken","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0750","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1093\/hmg\/11.22.2689","article-title":"Aggregate formation inhibits proteasomal degradation of polyglutamine proteins","volume":"11","author":"Verhoef","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0755","doi-asserted-by":"crossref","first-page":"11723","DOI":"10.1073\/pnas.96.21.11723","article-title":"Selection of antibodies for intracellular function using a two-hybrid in vivo system","volume":"96","author":"Visintin","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0760","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0765","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1083\/jcb.200710158","article-title":"Suppression of neuropil aggregates and neurological symptoms by an intracellular antibody implicates the cytoplasmic toxicity of mutant huntingtin","volume":"181","author":"Wang","year":"2008","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0770","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1073\/pnas.0308679101","article-title":"Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset","volume":"101","author":"Wexler","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0775","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1523\/JNEUROSCI.6698-10.2011","article-title":"Rapid active zone remodeling during synaptic plasticity","volume":"31","author":"Weyhersmuller","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0780","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1038\/nn.2690","article-title":"The same synaptic vesicles drive active and spontaneous release","volume":"13","author":"Wilhelm","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0785","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.bbadis.2010.05.004","article-title":"Murine models of Alzheimer's disease and their use in developing immunotherapies","volume":"1802","author":"Wisniewski","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0790","doi-asserted-by":"crossref","first-page":"11563","DOI":"10.1073\/pnas.0505321102","article-title":"Suppression of Huntington's disease pathology in Drosophila by human single-chain Fv antibodies","volume":"102","author":"Wolfgang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0795","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1172\/JCI17742","article-title":"Huntingtin in health and disease","volume":"111","author":"Young","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0850","doi-asserted-by":"crossref","first-page":"84ra44","DOI":"10.1126\/scitranslmed.3002230","article-title":"Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target","volume":"3","author":"Yu","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0805","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1161\/STROKEAHA.109.572537","article-title":"Recombinant Fv-Hsp70 protein mediates neuroprotection after focal cerebral ischemia in rats","volume":"41","author":"Zhan","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0810","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ymthe.2004.08.019","article-title":"A human single-chain Fv intrabody blocks aberrant cellular effects of overexpressed alpha-synuclein","volume":"10","author":"Zhou","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0815","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.bbadis.2008.09.001","article-title":"Intrabody and Parkinson's disease","volume":"1792","author":"Zhou","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0820","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1097-2765(00)00074-5","article-title":"Harnessing the ubiquitination machinery to target the degradation of specific cellular proteins","volume":"6","author":"Zhou","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.pneurobio.2011.11.004_bib0825","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00041.2009","article-title":"Molecular mechanisms and potential therapeutical targets in Huntington's disease","volume":"90","author":"Zuccato","year":"2010","journal-title":"Physiol. Rev."}],"container-title":["Progress in Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301008211002103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301008211002103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T04:42:33Z","timestamp":1639716153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301008211002103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":167,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0301008211002103"],"URL":"https:\/\/doi.org\/10.1016\/j.pneurobio.2011.11.004","relation":{},"ISSN":["0301-0082"],"issn-type":[{"value":"0301-0082","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}